A Randomized, Double-Blind, Placebo-Controlled, Parallel, Stratified, Multi-Center, 12-Week Study Comparing the Safety & Efficacy of Fluticasone and Formoterol Combination (FlutiForm(tm)100/10 microg Twice Daily) in a Single Inhaler (SkyePharma HFA pMDI)With the Administration of Placebo or Fluticasone (100 microg Twice Daily) and Formoterol (10 microg Twice Daily) Alone in Adolescent and Adult Patients With Mild to Moderate Asthma.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Parallel, Stratified, Multi-Center, 12-Week Study Comparing the Safety & Efficacy of Fluticasone and Formoterol Combination (FlutiForm(tm)100/10 microg Twice Daily) in a Single Inhaler (SkyePharma HFA pMDI)With the Administration of Placebo or Fluticasone (100 microg Twice Daily) and Formoterol (10 microg Twice Daily) Alone in Adolescent and Adult Patients With Mild to Moderate Asthma.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jun 2011

At a glance

  • Drugs Fluticasone propionate; Formoterol; Formoterol/fluticasone propionate
  • Indications Asthma
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 14 Sep 2009 Results presented at the 19th Annual Congress of the European Respiratory Society (ERS).
    • 19 May 2009 Results reported at the 105th International Conference of the American Thoracic Society.
    • 03 Jul 2008 Primary endpoint met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top